Jaguar Health, Inc.
NASDAQ Capital MarketTotal Valuation
Jaguar Health, Inc. carries a market capitalization of 214,581.00, placing it among publicly traded companies globally. Its enterprise value stands at 34.94M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 214,581.00 |
| Enterprise Value | 34.94M |
Share Statistics
Jaguar Health, Inc. currently has 371,979.00 shares outstanding.
| Shares Outstanding | 371,979.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
| EV / Sales | 1.18 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Jaguar Health, Inc. maintains a current ratio of 0.50, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -277.94, indicating conservative leverage, while an interest coverage ratio of -33.37 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.50 |
| Quick Ratio | 0.19 |
| Debt / Equity | -277.94 |
| Debt / EBITDA | -1.88 |
| Interest Coverage | -33.37 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -76.77 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 9.57 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.48 |
Stock Price Statistics
Jaguar Health, Inc.'s stock has declined approximately -97.79376% over the past 52 weeks. The 50-day moving average sits at 8.81, while the 200-day moving average is 37.75.
| Beta (5Y) | N/A |
| 52-Week Price Change | -97.79376% |
| 50-Day Moving Average | 8.81 |
| 200-Day Moving Average | 37.75 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Jaguar Health, Inc. generated 29.54M in revenue and converted that into -34.12M in net income, yielding earnings per share of -1,196.32. EBITDA reached -23.33M, while operating income came in at -25.50M.
| Revenue | 29.54M |
| Gross Profit | 25.13M |
| Operating Income | -25.50M |
| Pretax Income | -34.68M |
| Net Income | -34.12M |
| EBITDA | -23.33M |
| EBIT | -25.50M |
| Earnings Per Share (EPS) | -1,196.32 |
Balance Sheet
Jaguar Health, Inc. holds 7.28M in cash and equivalents against 43.78M in total debt, resulting in a net debt position of 35.34M. Total book value stands at -391.07M, with working capital of -20.48M providing operational flexibility.
| Cash & Cash Equivalents | 7.28M |
| Total Debt | 43.78M |
| Net Debt | 35.34M |
| Equity (Book Value) | -391.07M |
| Book Value Per Share | -13,490.93 |
| Working Capital | -20.48M |
Cash Flow
Jaguar Health, Inc. produced -7.54M in operating cash flow over the past twelve months. After subtracting -41,000.00 in capital expenditures, free cash flow totaled -7.58M - equivalent to -261.60 per share.
| Operating Cash Flow | -7.54M |
| Capital Expenditures | -41,000.00 |
| Free Cash Flow | -7.58M |
| FCF Per Share | -261.60 |
Margins
Jaguar Health, Inc. operates with a gross margin of 85.05, reflecting its pricing power and cost economics. The operating margin of -86.33 and net profit margin of -115.49 provide insight into operational efficiency.
| Gross Margin | 85.05 |
| Operating Margin | -86.33 |
| Pretax Margin | -117.38 |
| Profit Margin | -115.49 |
| EBITDA Margin | -78.96 |
Dividends & Yields
The company's payout ratio of 31.05 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 31.05 |
| Shareholder Yield | -112,562.54 |
| FCF Yield | -69,842.97 |
Stock Splits
Jaguar Health, Inc.'s most recent stock split took place on April 30, 2026 with a 35:1 split ratio.
| Last Split Date | 4/30/2026 |
| Split Ratio | 35:1 |
Scores
Jaguar Health, Inc. posts an Altman Z-Score of -28.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -28.64 |